Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montréal: results from three cross-sectional studies (2005, 2009, 2018)
| dc.contributor.author | Cox, Joseph | |
| dc.contributor.author | Klein, Marina | |
| dc.contributor.author | Lambert, Gilles | |
| dc.contributor.author | Grace, Daniel | |
| dc.contributor.author | Lachowsky, Nathan J. | |
| dc.contributor.author | Maheu-Giroux, Mathieu | |
| dc.contributor.author | Lanièce Delaunay, Charlotte | |
| dc.date.accessioned | 2022-03-07T23:42:18Z | |
| dc.date.available | 2022-03-07T23:42:18Z | |
| dc.date.copyright | 2021 | en_US |
| dc.date.issued | 2021 | |
| dc.description | The principal investigators of Argus are Michel Alary, Chris Archibald, Joseph Cox, Louis-Robert Frigault, Marc-André Gadoury, Gilles Lambert, René Lavoie, Robert Remis, Paul Sandstrom, Cécile Tremblay, François Tremblay and Jon Vincelette. The authors would like to thank all men who agreed to participate in the Argus surveys, as well as the owners and managers of the establishments where the participants were recruited. The authors would also like to thank the gay community organisations in Montréal who supported this research. The principal investigators of Engage are Joseph Cox, Daniel Grace, Trevor Hart, Jody Jollimore, Nathan Lachowsky, Gilles Lambert and David Moore. The authors would like to thank all the Engage participants, the community engagement committee members and the affiliated community agencies. | en_US |
| dc.description.abstract | Objectives: To eliminate the hepatitis C virus (HCV) by 2030, Canada must adopt a microelimination approach targeting priority populations, including gay, bisexual and other men who have sex with men (MSM). Accurately describing HCV prevalence and risk factors locally is essential to design appropriate prevention and treatment interventions. We aimed to estimate temporal trends in HCV seroprevalence between 2005 and 2018 among Montréal MSM, and to identify socioeconomic, behavioural and biological factors associated with HCV exposure among this population. Methods: We used data from three cross-sectional surveys conducted among Montréal MSM in 2005 (n=1795), 2009 (n=1258) and 2018 (n=1086). To ensure comparability of seroprevalence estimates across time, we standardised the 2005 and 2009 time-location samples to the 2018 respondent-driven sample. Time trends overall and stratified by HIV status, history of injection drug use (IDU) and age were examined. Modified Poisson regression analyses with generalised estimating equations were used to identify factors associated with HCV seropositivity pooling all surveys. Results: Standardised HCV seroprevalence among all MSM remained stable from 7% (95% CI 3% to 10%) in 2005, to 8% (95% CI 1% to 9%) in 2009 and 8% (95% CI 4% to 11%) in 2018. This apparent stability hides diverging temporal trends in seroprevalence between age groups, with a decrease among MSM <30 years old and an increase among MSM aged ≥45 years old. Lifetime IDU was the strongest predictor of HCV seropositivity, and no association was found between HCV seroprevalence and sexual risk factors studied (condomless anal sex with men of serodiscordant/ unknown HIV status, number of sexual partners, group sex). Conclusions: HCV seroprevalence remained stable among Montréal MSM between 2005 and 2018. Unlike other settings where HCV infection was strongly associated with sexual risk factors among MSM, IDU was the pre-eminent risk factor for HCV seropositivity. Understanding the intersection of IDU contexts, practices and populations is essential to prevent HCV transmission among MSM. | en_US |
| dc.description.reviewstatus | Reviewed | en_US |
| dc.description.scholarlevel | Faculty | en_US |
| dc.description.sponsorship | The Argus surveys were funded by the Institut national de santé publique du Québec and the Public Health Agency of Canada. Engage is funded by the Canadian Institutes of Health Research, the Canadian Foundation for AIDS Research, and the Ontario HIV Treatment Network. CLD received a PhD trainee fellowship from the Canadian Network on Hepatitis C. The Canadian Network on Hepatitis C is funded by a joint initiative of the Canadian Institutes of Health Research (NHC- 142832) and the Public Health Agency of Canada. CLD also received a doctoral training award from the Fonds de recherche du Québec – Santé. MK is supported by a Tier I Canada Research Chair. MM-G’s research programme is funded by a career award from the Fonds de recherche du Québec – Santé. The authors thank the Réseau de recherche en santé des populations du Québec (RRSPQ) for its contribution to the financing of this publication. | en_US |
| dc.identifier.citation | Delaunay, C. L., Cox, J., Klein, M., Lambert, G., Grace, D., Lachowsky, N. J., & Maheu-Giroux, M. (2020). “Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montréal: results from three cross-sectional studies (2005, 2009, 2018).” Sexually Transmitted Infections, 97, 290-296. DOI: https://doi.org/10.1136/sextrans-2020-054464 | en_US |
| dc.identifier.uri | https://doi.org/10.1136/sextrans-2020-054464 | |
| dc.identifier.uri | http://hdl.handle.net/1828/13783 | |
| dc.language.iso | en | en_US |
| dc.publisher | Sexually Transmitted Infections | en_US |
| dc.subject.department | School of Public Health and Social Policy | |
| dc.title | Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montréal: results from three cross-sectional studies (2005, 2009, 2018) | en_US |
| dc.type | Article | en_US |